ARPM. By dispelling the myths we develop innovation
“Production of modern innovative drugs today is not only risky in terms of return on investment, but also costly in…
“Production of modern innovative drugs today is not only risky in terms of return on investment, but also costly in…
Russian pharma showed its great potential at the 27th international pharmaceutical exhibition CPhI. The Russia industry was represented by entrepreneurs…
The 7th conference “Current situation on the pharmaceutical market” took place in Moscow. The event’s agenda on price formation and…
The XII Forum of Interregional Cooperation of Russia and Kazakhstan took place in Astana. The event, which…
The 19th European Health Forum Gastein brought together 600 businessman, researchers, and state officials from around the world. The Russian…
The Fourth Partnering “Russian Medicine. An interdisciplinary dialogue” took place in Kazan. This annual event, hosted by the Federal Antimonopoly…
“The issue of proc formation from the low price segment still has not been resolved. Despite the President’s order, some…
The amendments made based on recommendations of the Association of the Russian Pharmaceutical Manufacturers on the issuance of the CT-1…
A Russia- Chinese business meeting took place in St. Petersburg on September 17. The Chinese counterparts led by the Jinan…
The Russian pharmaceutical industry expands its modern production facilities. A new modern production plant of “Skopinopharm” (affiliated with “Pharmimex”)…